1. is there any logic to starting IGRT prior to psa 0.2 ng/ml ? Will insurance cover IGRT if started too soon? Yes, there is some logic to reacting sooner. In a recent study among men with pT2 (like yours) they found that PSAs higher than 0.03 predicted biochemical recurrence, and gave a 33 month lead-time advantage over waiting for PSA to go up to 0.2. They also found negative margins (like yours) were faster growing.
I've never heard of insurance problem with earlier SRT, but it can't hurt to get pre-authorization.
Ultrasensitive PSA Identifies Patients With Organ-Confined Prostate Cancer Requiring Postop Radiotherapy4. Does my doubling time of 4 months really mean anything with these low psa numbers? Or does it only matter after psa hits 0.1 and higher?In another study, they found that men with PSA≥0.03 who had a PSA rise ≥ 0.05 within a year often went onto full biochemical recurrence. But they did not break out separately men with adverse pathology.
Low detectable PSA after prostatectomy – watch or treat?A recent study at Johns Hopkins also found 0.03 on the
first 3-month PSA to be predictive.
Johns Hopkins: ultrasensitive PSA after surgery predicts biochemical relapse2. Is hormone therapy ADT overkill at this point? Seems like I would want to know if the radiation is working before ADT, otherwise I may never know if my psa drops.ADT with radiation is a temporary adjuvant treatment, and you will have a respite afterwards where they can track any PSA progression. Recent evidence is that ADT may improve outcomes for men with Gleason 4+3. But read the caveats at the bottom of the following:
Combining ADT and salvage radiation therapy improves outcomes3. Any other treatment options I should consider?Even given all the above, PC progression is usually very slow and it is unclear what PSA one can wait for before late treatment impairs survival. A UCSF study with 6 years median follow up, found that when patients waited for PSAs to rise above 1.0, their risk of metastases and PC mortality rose considerably. With longer follow up, it may be that earlier SRT saves more lives - we just don't know yet.
Another diagnostic worth considering is called Decipher. It's expensive, but approved by Medicare and most insurance (check first!). It tells one after surgery the risk of metastases in the next 5 years. It's pretty good at predicting which ones won't progress in that timeframe, but not so good at predicting those that will.
There is a clinical trial now for completing salvage RT in a shorter time. Early results have been excellent.
- Allen